# OraSure Announces First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/OSUR/orasure-announces-first-quarter-2026-financial-results
Ticker: OSUR
Company: OraSure Technologies, Inc.
Source: OraSure Technologies, Inc.
Published: 2026-05-06 20:05 EST
Original Source URL: https://orasure.gcs-web.com
## Summary

BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2026.

## Article Body
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2026.
## Recent Company News
- 2026-05-06 20:05 EST — [OraSure Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-first-quarter-2026-financial-results) — Source: OraSure Technologies, Inc.
- 2026-04-22 20:10 EST — [OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th](https://biopharmsignal.com/news/OSUR/orasure-to-announce-first-quarter-2026-financial-results-and-host-earnings-call-on-may-6th) — Source: OraSure Technologies, Inc.
- 2026-04-17 00:10 EST — [OraSure Technologies Appoints John D. Bertrand to its Board of Directors](https://biopharmsignal.com/news/OSUR/orasure-technologies-appoints-john-d-bertrand-to-its-board-of-directors) — Source: OraSure Technologies, Inc.
- 2026-03-17 20:53 EST — [OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital](https://biopharmsignal.com/news/OSUR/orasure-highlights-significant-operational-progress-and-value-creation-initiatives-following-letter-from-altai-capital) — Source: OraSure Technologies, Inc.
- 2026-02-25 21:05 EST — [OraSure Announces Fourth Quarter 2025 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-fourth-quarter-2025-financial-results) — Source: OraSure Technologies, Inc.
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)